<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Given the lack of a serological test specific for <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease, its diagnosis rests upon clinical criteria </plain></SENT>
<SENT sid="1" pm="."><plain>The clinical diagnosis is nevertheless difficult because the disease manifestations vary widely, especially at the <z:hpo ids='HP_0003674'>onset</z:hpo> of disease </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this study was to identify molecules specifically recognized by serum autoantibodies in patients with <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease and to evaluate their diagnostic value </plain></SENT>
<SENT sid="3" pm="."><plain>We screened a cDNA library from human microvascular endothelial cells with serum IgG from two patients with <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease and isolated a reactive clone specific to the carboxy-terminal subunit of Sip1 (Sip1 C-ter) </plain></SENT>
<SENT sid="4" pm="."><plain>Using ELISA, we measured IgG, IgM and IgA specific to Sip1 C-ter in patients with various <z:hpo ids='HP_0002960'>autoimmune diseases</z:hpo> characterized by the presence of serum anti-endothelial cell antibodies, such as <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease, <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo>, systemic <z:mp ids='MP_0000612'>sclerosis</z:mp> and various forms of primary <z:hpo ids='HP_0002633'>vasculitis</z:hpo>, as well as in patients with diseases that share clinical features with <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease, such as <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> and <z:hpo ids='HP_0000554'>uveitis</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>IgM immunoreactivity to Sip1 C-ter was significantly higher in patients with <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease and in patients with primary <z:hpo ids='HP_0002633'>vasculitis</z:hpo> than in the other groups of patients and healthy subjects tested (P &lt; 10-4 by Mann-Whitney test) </plain></SENT>
<SENT sid="6" pm="."><plain>ELISA detected IgG specific to Sip1 C-ter in sera from 11/56 (20%) patients with <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease, IgM in 23/56 (41%) and IgA in 9/54 (17%) </plain></SENT>
<SENT sid="7" pm="."><plain>No sera from patients with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo>, systemic <z:mp ids='MP_0000612'>sclerosis</z:mp>, <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e>, <z:hpo ids='HP_0000554'>uveitis</z:hpo> or healthy subjects but 45% of sera from patients with primary <z:hpo ids='HP_0002633'>vasculitis</z:hpo> contained IgM specific to Sip1 C-ter </plain></SENT>
<SENT sid="8" pm="."><plain>Serum levels of soluble E-selectin, a marker of endothelial activation and <z:mp ids='MP_0001845'>inflammation</z:mp>, correlated with levels of serum IgM anti Sip-1 C-ter in patients with <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease (r = 0.36, P = 0.023) </plain></SENT>
<SENT sid="9" pm="."><plain>In conclusion, Sip1 C-ter is a novel autoantigen in <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease </plain></SENT>
<SENT sid="10" pm="."><plain>IgM specific to Sip1 C-ter might be useful in clinical practice as an immunological marker of <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e> in <z:hpo ids='HP_0002633'>vasculitis</z:hpo> </plain></SENT>
</text></document>